Search
Xtant Medical Holdings Inc
XTNTAdd to Watchlist
0.440USD
+0.020+4.76%
Market hours （ET）Quotes delayed by 15 min
61.62MMarket Cap
33.43P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-01The current earnings forecast score of Xtant Medical Holdings Inc is 8.67, ranking 16 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 1.50, with a high of 1.50 and a low of 1.50.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
1.233
Target Price
+192.95%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Xtant Medical Holdings Inc
XTNT
3
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
31
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Xtant Medical Holdings Inc's expected revenue for the next quarter?
Xtant Medical Holdings Inc's expected revenue is 24.48M.
What is Xtant Medical Holdings Inc's price target?
Analysts forecast that Xtant Medical Holdings Inc's price target is USD 1.50, with the highest forecast at USD 1.50 and the lowest forecast at USD 1.50.
What is the analyst rating for Xtant Medical Holdings Inc?
Based on the ratings of Xtant Medical Holdings Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.